Portfolio
Understanding the role of KMT2D in MLL-AF9 acute myeloid leukemia
Damon Runyon - Mark Foundation Physician-Scientist (2023-Present)
Nicole Cruz, MD, The Rockefeller University
Chemical Hijacking of E3 Ligases for the Selective Targeting of Oncogenic mTOR Signaling
ASPIRE Award (2023-Present)
Cristina Mayor-Ruiz, PhD; Antoni Riera Escalé, PhD, Institute for Research in Biomedicine (IRB Barcelona), Spain; Alejo Efeyan, PhD, Centro Nacional de Investigaciones Oncológicas (CNIO), Spain
Exploiting Protein Structural Dynamics for New Uveal Melanoma Therapies
ASPIRE Award (2023-Present)
Aashish Manglik, MD, PhD; Michelle Arkin, PhD; Boris Bastian, MD, PhD, University of California, San Francisco
Chemical Repair of an Oncogenic Mutation in p53
ASPIRE Award (2023-Present)
Nir London, PhD, The Weizmann Institute of Science, Israel
Lessons from Ancient Mechanisms of Tumor-Host Interactions
ASPIRE Award (2023-Present)
David Bilder, PhD, University of California, Berkeley
Identification of Specific Dietary Fats that Fuel Cancer
2023 Emerging Leader Award
Lydia Lynch, PhD, Brigham and Women's Hospital, Harvard Medical School
Examining the Link between Chromosomal Instability and Epigenetic Reprogramming in Cancer
2023 Emerging Leader Award
Samuel Bakhoum, MD, PhD, Memorial Sloan Kettering Cancer Center
In Situ Dynamics of Distant Metastases
2023 Emerging Leader Award
Mikhail Shapiro, PhD, California Institute of Technology
Tracking and Reactivating Humoral Immunity through Systems Serology
2023 Emerging Leader Award
Aaron Meyer, PhD, University of California, Los Angeles
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you agree to our Terms of Use and Privacy Policy.OkPrivacy Policy and Terms of Use